tacrine has been researched along with caproctamine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrisano, V; Bolognesi, ML; Budriesi, R; Cavalli, A; Cavrini, V; Melchiorre, C; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
| Andrisano, V; Angeli, P; Banzi, R; Bartolini, M; Cavalli, A; Marucci, G; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
| Andrisano, V; Banzi, R; Bartolini, M; Bolognesi, ML; Melchiorre, C | 1 |
| Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
| Lv, W; Xue, Y | 1 |
1 review(s) available for tacrine and caproctamine
| Article | Year |
|---|---|
Multi-target-directed ligands to combat neurodegenerative diseases.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid | 2008 |
4 other study(ies) available for tacrine and caproctamine
| Article | Year |
|---|---|
Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Erythrocytes; Humans; Kinetics; Ligands; Models, Molecular; Polyamines; Receptor, Muscarinic M2; Receptors, Muscarinic; Structure-Activity Relationship | 1998 |
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine.
Topics: Acetylcholinesterase; Amides; Animals; Anisoles; Atrial Function; Butyrylcholinesterase; Cholinesterase Inhibitors; Diaphragm; Guinea Pigs; Heart Atria; Humans; In Vitro Techniques; Models, Molecular; Muscarinic Antagonists; Myocardial Contraction; Neuromuscular Blockade; Neuromuscular Junction; Polyamines; Rats; Receptor, Muscarinic M2; Receptors, Muscarinic; Stereoisomerism; Structure-Activity Relationship | 2003 |
Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Biochemistry; Cholinesterase Inhibitors; Dimerization; Drug Design; Drug Evaluation, Preclinical; Fluorometry; Humans; Hydrolysis; Inhibitory Concentration 50; Ligands; Polyamines; Propidium; Structure-Activity Relationship | 2005 |
Prediction of acetylcholinesterase inhibitors and characterization of correlative molecular descriptors by machine learning methods.
Topics: Algorithms; Artificial Intelligence; Cholinesterase Inhibitors; Computational Biology; Drug Design; Models, Chemical; Quantitative Structure-Activity Relationship | 2010 |